Get the Stockscreener App
39.57
1.49%
-0.60
After Hours:
39.54
-0.03
-0.08%
Procept Biorobotics Corp stock is traded at $39.57, with a volume of 1.53M.
It is down -1.49% in the last 24 hours and down -20.80% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$40.17
Open:
$41.885
24h Volume:
1.53M
Relative Volume:
1.43
Market Cap:
$2.20B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-23.28
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-2.34%
1M Performance:
-20.80%
6M Performance:
-38.50%
1Y Performance:
-49.91%
1-Day Range:
$39.20
$42.43
1-Week Range:
$39.20
$42.43
52-Week Range:
$37.12
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
39.57 | 2.23B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Using AI based signals to follow PROCEPT BioRobotics Corporation2025 Retail Activity & Precise Swing Trade Entry Alerts - Newser
Using data tools to time your PROCEPT BioRobotics Corporation exitJuly 2025 Volume & Real-Time Stock Price Movement Reports - Newser
Applying Elliott Wave Theory to PROCEPT BioRobotics CorporationEarnings Growth Summary & Entry and Exit Point Strategies - Newser
PROCEPT BioRobotics Corporation stock daily chart insightsMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
What’s the recovery path for long term holders of PROCEPT BioRobotics Corporation2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Procept Offers Attractive Risk-Reward, Oppenheimer Says - MarketScreener
Procept BioRobotics stock upgraded by Oppenheimer on attractive risk-reward - Investing.com
Institutional scanner results for PROCEPT BioRobotics CorporationJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Procept BioRobotics upgraded to Outperform from Perform at Oppenheimer - TipRanks
Will PROCEPT BioRobotics Corporation stock go up soonDollar Strength & Reliable Intraday Trade Alerts - Newser
Oppenheimer Upgrades PROCEPT BioRobotics to Outperform From Market Perform, Price Target is $60 - MarketScreener
Using R and stats models for PROCEPT BioRobotics Corporation forecastingJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
What recovery options are there for PROCEPT BioRobotics Corporation2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Can PROCEPT BioRobotics Corporation reach all time highs this yearAnalyst Upgrade & Entry Point Confirmation Alerts - خودرو بانک
What are PROCEPT BioRobotics Corporation’s growth leversWeekly Market Report & Daily Stock Trend Watchlist - خودرو بانک
Will PROCEPT BioRobotics Corporation face regulatory challenges2025 Trading Recap & AI Forecasted Entry and Exit Points - خودرو بانک
Real time social sentiment graph for PROCEPT BioRobotics Corporation2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Does PROCEPT BioRobotics Corporation stock reflect fundamentalsTrade Exit Summary & Entry Point Strategy Guides - خودرو بانک
Smart tools for monitoring PROCEPT BioRobotics Corporation’s price actionTreasury Yields & Technical Pattern Based Buy Signals - Newser
How cyclical is PROCEPT BioRobotics Corporation’s revenue streamJuly 2025 Setups & Momentum Based Trading Ideas - خودرو بانک
Is PROCEPT BioRobotics Corporation a candidate for recovery playMarket Activity Report & Safe Capital Allocation Plans - Newser
Will PROCEPT BioRobotics Corporation benefit from sector rotationQuarterly Market Summary & Daily Entry Point Trade Alerts - خودرو بانک
Volume spikes in PROCEPT BioRobotics Corporation stock – what they meanTrend Reversal & Fast Exit/Entry Strategy Plans - Newser
Can PROCEPT BioRobotics Corporation hit a new high this monthJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Volatility clustering patterns for PROCEPT BioRobotics CorporationWeekly Gains Report & AI Powered Market Trend Analysis - Newser
PROCEPT BioRobotics Corporation stock retracement – recovery analysisIPO Watch & Safe Capital Preservation Plans - Newser
Will PROCEPT BioRobotics Corporation Benefit From Broader Market Bounce getLinesFromResByArray error: size == 0 - news-j.co.kr
Using data models to predict PROCEPT BioRobotics Corporation stock movementJuly 2025 Summary & Daily Price Action Insights - Newser
Analyzing PROCEPT BioRobotics Corporation with risk reward ratio chartsWeekly Trading Summary & Community Verified Trade Signals - Newser
Can momentum traders help lift PROCEPT BioRobotics CorporationBull Run & Fast Exit/Entry Strategy Plans - Newser
Ranking PROCEPT BioRobotics Corporation among high performing stocks via toolsBuy Signal & Fast Exit/Entry Strategy Plans - Newser
Best data tools to analyze PROCEPT BioRobotics Corporation stockWatch List & Real-Time Buy Signal Alerts - Newser
Is PROCEPT BioRobotics Corporation building a consolidation baseJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Statistical indicators supporting PROCEPT BioRobotics Corporation’s strengthAnalyst Downgrade & Risk Managed Trade Strategies - Newser
Is PROCEPT BioRobotics Corporation trending in predictive chart models2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Will PROCEPT BioRobotics Corporation bounce back from current supportEntry Point & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-31 06:47:50 - Newser
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
Short interest data insights for PROCEPT BioRobotics CorporationEarnings Growth Report & Smart Investment Allocation Insights - Newser
What momentum shifts mean for PROCEPT BioRobotics CorporationShort Setup & Smart Swing Trading Alerts - Newser
What MACD signals say about PROCEPT BioRobotics Corporation2025 Winners & Losers & Real-Time Buy Signal Alerts - Newser
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):